Catalyst Event
Innovent Biologics Inc (1801) · Other
From Akros SCHK HK-U.S. Tech 100 Index (ASHUSTC)
5/29/2026, 12:00:00 AM
Announcement of strategic global licensing agreement with Pfizer for 12 cancer medicines ($10.5B total value); >10% price impact estimated due to massive deal size expected
Korean Translation
화이자와 105억 달러 규모의 항암제 12종 글로벌 라이선스 계약 체결 발표; 대규모 계약으로 10% 이상의 주가 영향이 예상됨
Related Recent Events
Xiaomi Corporation (1810) · Earnings Release
Q2 2026 earnings release is scheduled. A low market impact is estimated as the specific financial results are not yet disclosed.
8/26/2026, 12:00:00 AM
Amazon.com Inc (AMZN) · Earnings Release
Amazon's Q2 2026 earnings release is expected on July 30, 2026. The company guided for net sales between $194.0 billion and $199.0 billion. Low importance is assigned as the market reaction has not yet occurred expected.
7/30/2026, 12:00:00 AM
Meta Platforms Inc (META) · Earnings Release
Meta Platforms is expected to release its Q2 2026 financial results after market close on July 29, 2026. Due to historical volatility during earnings for mega-cap tech stocks, a high price impact (>10%) is expected.
7/29/2026, 12:00:00 AM
Lam Research Corp (LRCX) · Earnings Release
Lam Research is expected to report its Q4 2026 earnings on July 29, 2026. Analysts forecast an EPS of approximately $1.65-$1.68. Market impact is estimated at Medium as earnings reports typically drive significant price volatility, scheduled.
7/29/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Earnings Release
Alphabet Q2 2026 earnings release scheduled for July 22, 2026, with analysts forecasting EPS of approximately $2.85-$2.87 forecasted.
7/22/2026, 12:00:00 AM
International Business Machines Corp (IBM) · Earnings Release
IBM's Q2 2026 earnings announcement is scheduled for July 22, 2026, scheduled
7/22/2026, 12:00:00 AM